The U.S. eldercare market reached $381.6 billion in 2014 and nearly $417 billion in 2015. The market should reach $512.7 billion in 2020, demonstrating a compound annual growth rate (CAGR) of 4.2% from 2015 to 2020.
This report provides:
An overview of the global markets for eldercare products and services.
Analyses of market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020.
Segmentations of the market into healthcare products and services, housing services and needs, and assistive technologies.
Breakdowns of the U.S. and worldwide markets by demographics.
A focus on applications including:
Kidney disease medications.
Arthritis prescription medications.
Neurological health medications (e.g., dementia, depression).
Respiratory medications and products.
Information covering the industry's structure.
Profiles of major players in the industry.
SCOPE OF REPORT
This report offers forecasts by product segment (i.e., healthcare, housing, and assistive devices and technology) from 2015 through 2020, including supporting analyses for projections.
Report segments include a demographic background of the market in the U.S. and worldwide, healthcare products and services, housing services and needs, and assistive technologies for the elder care market. International markets are discussed and information is provided on industry structure.
Profiles of leading companies involved in the elder care pharmaceutical, housing and assistive device industries are provided. Information on company placement within the designated market and strategic analyses of the companies’ available and emerging products are discussed.